Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved..
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the United Kingdom to accelerate population coverage with a single dose. At this time, trial data were lacking, and we addressed this in a study of United Kingdom healthcare workers. The first vaccine dose induced protection from infection from the circulating alpha (B.1.1.7) variant over several weeks. In a substudy of 589 individuals, we show that this single dose induces severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibody (NAb) responses and a sustained B and T cell response to the spike protein. NAb levels were higher after the extended dosing interval (6-14 weeks) compared with the conventional 3- to 4-week regimen, accompanied by enrichment of CD4+ T cells expressing interleukin-2 (IL-2). Prior SARS-CoV-2 infection amplified and accelerated the response. These data on dynamic cellular and humoral responses indicate that extension of the dosing interval is an effective immunogenic protocol.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:184 |
|---|---|
| Enthalten in: |
Cell - 184(2021), 23 vom: 11. Nov., Seite 5699-5714.e11 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Payne, Rebecca P [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 23.11.2021 Date Revised 04.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cell.2021.10.011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332738922 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332738922 | ||
| 003 | DE-627 | ||
| 005 | 20240404232741.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cell.2021.10.011 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1364.xml |
| 035 | |a (DE-627)NLM332738922 | ||
| 035 | |a (NLM)34735795 | ||
| 035 | |a (PII)S0092-8674(21)01221-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Payne, Rebecca P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.11.2021 | ||
| 500 | |a Date Revised 04.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the United Kingdom to accelerate population coverage with a single dose. At this time, trial data were lacking, and we addressed this in a study of United Kingdom healthcare workers. The first vaccine dose induced protection from infection from the circulating alpha (B.1.1.7) variant over several weeks. In a substudy of 589 individuals, we show that this single dose induces severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibody (NAb) responses and a sustained B and T cell response to the spike protein. NAb levels were higher after the extended dosing interval (6-14 weeks) compared with the conventional 3- to 4-week regimen, accompanied by enrichment of CD4+ T cells expressing interleukin-2 (IL-2). Prior SARS-CoV-2 infection amplified and accelerated the response. These data on dynamic cellular and humoral responses indicate that extension of the dosing interval is an effective immunogenic protocol | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a B cell | |
| 650 | 4 | |a BNT162b2 | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a T cell | |
| 650 | 4 | |a antibody | |
| 650 | 4 | |a dosing interval | |
| 650 | 4 | |a neutralization | |
| 650 | 4 | |a vaccine | |
| 650 | 4 | |a variants of concern | |
| 650 | 7 | |a Antibodies, Neutralizing |2 NLM | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 650 | 7 | |a Vaccines, Synthetic |2 NLM | |
| 650 | 7 | |a BNT162 Vaccine |2 NLM | |
| 650 | 7 | |a N38TVC63NU |2 NLM | |
| 700 | 1 | |a Longet, Stephanie |e verfasserin |4 aut | |
| 700 | 1 | |a Austin, James A |e verfasserin |4 aut | |
| 700 | 1 | |a Skelly, Donal T |e verfasserin |4 aut | |
| 700 | 1 | |a Dejnirattisai, Wanwisa |e verfasserin |4 aut | |
| 700 | 1 | |a Adele, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Meardon, Naomi |e verfasserin |4 aut | |
| 700 | 1 | |a Faustini, Sian |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Taei, Saly |e verfasserin |4 aut | |
| 700 | 1 | |a Moore, Shona C |e verfasserin |4 aut | |
| 700 | 1 | |a Tipton, Tom |e verfasserin |4 aut | |
| 700 | 1 | |a Hering, Luisa M |e verfasserin |4 aut | |
| 700 | 1 | |a Angyal, Adrienn |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Rebecca |e verfasserin |4 aut | |
| 700 | 1 | |a Nicols, Alexander R |e verfasserin |4 aut | |
| 700 | 1 | |a Gillson, Natalie |e verfasserin |4 aut | |
| 700 | 1 | |a Dobson, Susan L |e verfasserin |4 aut | |
| 700 | 1 | |a Amini, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Supasa, Piyada |e verfasserin |4 aut | |
| 700 | 1 | |a Cross, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Bridges-Webb, Alice |e verfasserin |4 aut | |
| 700 | 1 | |a Reyes, Laura Silva |e verfasserin |4 aut | |
| 700 | 1 | |a Linder, Aline |e verfasserin |4 aut | |
| 700 | 1 | |a Sandhar, Gurjinder |e verfasserin |4 aut | |
| 700 | 1 | |a Kilby, Jonathan A |e verfasserin |4 aut | |
| 700 | 1 | |a Tyerman, Jessica K |e verfasserin |4 aut | |
| 700 | 1 | |a Altmann, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Hornsby, Hailey |e verfasserin |4 aut | |
| 700 | 1 | |a Whitham, Rachel |e verfasserin |4 aut | |
| 700 | 1 | |a Phillips, Eloise |e verfasserin |4 aut | |
| 700 | 1 | |a Malone, Tom |e verfasserin |4 aut | |
| 700 | 1 | |a Hargreaves, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Shields, Adrian |e verfasserin |4 aut | |
| 700 | 1 | |a Saei, Ayoub |e verfasserin |4 aut | |
| 700 | 1 | |a Foulkes, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Stafford, Lizzie |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, Sile |e verfasserin |4 aut | |
| 700 | 1 | |a Wootton, Daniel G |e verfasserin |4 aut | |
| 700 | 1 | |a Conlon, Christopher P |e verfasserin |4 aut | |
| 700 | 1 | |a Jeffery, Katie |e verfasserin |4 aut | |
| 700 | 1 | |a Matthews, Philippa C |e verfasserin |4 aut | |
| 700 | 1 | |a Frater, John |e verfasserin |4 aut | |
| 700 | 1 | |a Deeks, Alexandra S |e verfasserin |4 aut | |
| 700 | 1 | |a Pollard, Andrew J |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Anthony |e verfasserin |4 aut | |
| 700 | 1 | |a Rowland-Jones, Sarah L |e verfasserin |4 aut | |
| 700 | 1 | |a Mongkolsapaya, Juthathip |e verfasserin |4 aut | |
| 700 | 1 | |a Barnes, Eleanor |e verfasserin |4 aut | |
| 700 | 1 | |a Hopkins, Susan |e verfasserin |4 aut | |
| 700 | 1 | |a Hall, Victoria |e verfasserin |4 aut | |
| 700 | 1 | |a Dold, Christina |e verfasserin |4 aut | |
| 700 | 1 | |a Duncan, Christopher J A |e verfasserin |4 aut | |
| 700 | 1 | |a Richter, Alex |e verfasserin |4 aut | |
| 700 | 1 | |a Carroll, Miles |e verfasserin |4 aut | |
| 700 | 1 | |a Screaton, Gavin |e verfasserin |4 aut | |
| 700 | 1 | |a de Silva, Thushan I |e verfasserin |4 aut | |
| 700 | 1 | |a Turtle, Lance |e verfasserin |4 aut | |
| 700 | 1 | |a Klenerman, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Dunachie, Susanna |e verfasserin |4 aut | |
| 700 | 0 | |a PITCH Consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Abuelgasim, Hibatullah |e investigator |4 oth | |
| 700 | 1 | |a Adland, Emily |e investigator |4 oth | |
| 700 | 1 | |a Adlou, Syed |e investigator |4 oth | |
| 700 | 1 | |a Akther, Hossain Delowar |e investigator |4 oth | |
| 700 | 1 | |a Alhussni, Ahmed |e investigator |4 oth | |
| 700 | 1 | |a Ali, Mohammad |e investigator |4 oth | |
| 700 | 1 | |a Ansari, M Azim |e investigator |4 oth | |
| 700 | 1 | |a Arancibia-Cárcamo, Carolina V |e investigator |4 oth | |
| 700 | 1 | |a Bayley, Martin |e investigator |4 oth | |
| 700 | 1 | |a Brown, Helen |e investigator |4 oth | |
| 700 | 1 | |a Chalk, Jeremy |e investigator |4 oth | |
| 700 | 1 | |a Chand, Meera |e investigator |4 oth | |
| 700 | 1 | |a Chawla, Anu |e investigator |4 oth | |
| 700 | 1 | |a Chinnakannan, Senthil |e investigator |4 oth | |
| 700 | 1 | |a Cutteridge, Joseph |e investigator |4 oth | |
| 700 | 1 | |a de Lara, Catherine |e investigator |4 oth | |
| 700 | 1 | |a Denly, Lucy |e investigator |4 oth | |
| 700 | 1 | |a Diffey, Ben |e investigator |4 oth | |
| 700 | 1 | |a Dimitriadis, Stavros |e investigator |4 oth | |
| 700 | 1 | |a Drake, Thomas M |e investigator |4 oth | |
| 700 | 1 | |a Donnison, Timothy |e investigator |4 oth | |
| 700 | 1 | |a Dupont, Maeva |e investigator |4 oth | |
| 700 | 1 | |a Eyre, David |e investigator |4 oth | |
| 700 | 1 | |a Fairman, Alex |e investigator |4 oth | |
| 700 | 1 | |a Gardiner, Siobhan |e investigator |4 oth | |
| 700 | 1 | |a Gilbert-Jarmillo, Javier |e investigator |4 oth | |
| 700 | 1 | |a Goulder, Philip |e investigator |4 oth | |
| 700 | 1 | |a Hackstein, Carl-Philipp |e investigator |4 oth | |
| 700 | 1 | |a Hambleton, Sophie |e investigator |4 oth | |
| 700 | 1 | |a Haniffa, Muzlifah |e investigator |4 oth | |
| 700 | 1 | |a Haworth, Jenny |e investigator |4 oth | |
| 700 | 1 | |a Holmes, Jennifer |e investigator |4 oth | |
| 700 | 1 | |a Horner, Emily |e investigator |4 oth | |
| 700 | 1 | |a Jämsén, Anni |e investigator |4 oth | |
| 700 | 1 | |a Johnson, Sile |e investigator |4 oth | |
| 700 | 1 | |a Jones, Chris |e investigator |4 oth | |
| 700 | 1 | |a Kasanyinga, Mwila |e investigator |4 oth | |
| 700 | 1 | |a Kelly, Sinead |e investigator |4 oth | |
| 700 | 1 | |a Kirk, Rosemary |e investigator |4 oth | |
| 700 | 1 | |a Knight, Michael L |e investigator |4 oth | |
| 700 | 1 | |a Lawrie, Allan |e investigator |4 oth | |
| 700 | 1 | |a Lee, Lian |e investigator |4 oth | |
| 700 | 1 | |a Lett, Lauren |e investigator |4 oth | |
| 700 | 1 | |a Lillie, Katy |e investigator |4 oth | |
| 700 | 1 | |a Lim, Nicholas |e investigator |4 oth | |
| 700 | 1 | |a Mehta, Hema |e investigator |4 oth | |
| 700 | 1 | |a Mentzer, Alexander J |e investigator |4 oth | |
| 700 | 1 | |a O'Donnell, Denise |e investigator |4 oth | |
| 700 | 1 | |a Ogbe, Ane |e investigator |4 oth | |
| 700 | 1 | |a Pace, Matthew |e investigator |4 oth | |
| 700 | 1 | |a Payne, Brendan A I |e investigator |4 oth | |
| 700 | 1 | |a Platt, Gareth |e investigator |4 oth | |
| 700 | 1 | |a Poolan, Sonia |e investigator |4 oth | |
| 700 | 1 | |a Provine, Nicholas |e investigator |4 oth | |
| 700 | 1 | |a Ramamurthy, Narayan |e investigator |4 oth | |
| 700 | 1 | |a Robinson, Nichola |e investigator |4 oth | |
| 700 | 1 | |a Romaniuk, Leigh |e investigator |4 oth | |
| 700 | 1 | |a Rongkard, Patpong |e investigator |4 oth | |
| 700 | 1 | |a Sampson, Oliver L |e investigator |4 oth | |
| 700 | 1 | |a Simmons, Beatrice |e investigator |4 oth | |
| 700 | 1 | |a Spegarova, Jarmila S |e investigator |4 oth | |
| 700 | 1 | |a Stephenson, Emily |e investigator |4 oth | |
| 700 | 1 | |a Subramaniam, Kris |e investigator |4 oth | |
| 700 | 1 | |a Thaventhiran, James |e investigator |4 oth | |
| 700 | 1 | |a Thomas, Sarah |e investigator |4 oth | |
| 700 | 1 | |a Travis, Simon |e investigator |4 oth | |
| 700 | 1 | |a Tucker, Stephanie |e investigator |4 oth | |
| 700 | 1 | |a Turton, Helena |e investigator |4 oth | |
| 700 | 1 | |a Watson, Adam |e investigator |4 oth | |
| 700 | 1 | |a Watson, Lisa |e investigator |4 oth | |
| 700 | 1 | |a Weeks, Esme |e investigator |4 oth | |
| 700 | 1 | |a Wilson, Robert |e investigator |4 oth | |
| 700 | 1 | |a Wood, Steven |e investigator |4 oth | |
| 700 | 1 | |a Wright, Rachel |e investigator |4 oth | |
| 700 | 1 | |a Xiao, Huiyuan |e investigator |4 oth | |
| 700 | 1 | |a Zawia, Amira A T |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Cell |d 1974 |g 184(2021), 23 vom: 11. Nov., Seite 5699-5714.e11 |w (DE-627)NLM000088935 |x 1097-4172 |7 nnns |
| 773 | 1 | 8 | |g volume:184 |g year:2021 |g number:23 |g day:11 |g month:11 |g pages:5699-5714.e11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cell.2021.10.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 184 |j 2021 |e 23 |b 11 |c 11 |h 5699-5714.e11 | ||